Immunic Statistics
NASDAQ: IMUXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.63-0.19 (-2.43%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 7.80 +2.23%
Immunic by the numbers
Immunic has a market capitalization of $104.1 million based on 13.64M shares outstanding. With trailing EPS of $-3.83, Immunic is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 41.1% below its 50-day average and 32.9% below its 200-day average.
Average daily trading volume is 275.74K shares, or about $2.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMUX valuation vs. peer median
| Metric | IMUX | Peer median | Difference |
|---|---|---|---|
| Market cap | $104.11M | $103.71M | +0% |
| Avg. volume | 275.74K | 237.42K | +16% |
Peer median across 8 companies: PLYX, CPIX, ANIX, KZIA, CRBP, AARD, BMEA, OKUR.
Valuation
- Market cap
- $104.11M
- EPS (TTM)
- $-3.83
- Shares outstanding
- 13.64M
Price and trading
- Previous close
- 7.82
- Open
- 7.75
- Day range
- 7.49 – 7.90
- 52-week range
- 5.06 – 17.43
- 52-week change
- -13.30%
- Beta
- —
- Volume
- 367.58K
- Average volume
- 275.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 104.11M
- Forward Pe
- -3.14
- Eps
- -3.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.43
- Week52 Low
- 5.06
- Avg Volume
- 275.74K
- Shares Outstanding
- 13.64M
- Ma50
- 12.96
- Ma200
- 11.37
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -56.22%
- Pct From52w Low
- 50.79%